Anpac Bio Receives 'Series B' Funding from Shanghai Zhangjiang Science & Technology Investment Corp & Private Insurance Investors

Corporate Breaking News

Home : Anpac Bio Receives 'Series B' Funding from Shanghai Zhangjiang Science & Technology Investment Corp & Private Insurance Investors

Dec 25 2015	Anpac Bio Receives 'Series B' Funding from Shanghai Zhangjiang Science & Technology Investment Corp & Private Insurance Investors
SACRAMENTO, Calif., Dec. 24, 2015 /PRNewswire/ -- Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer Dr. Chris Yu announced that Venture Capital (VC) Firm, Shanghai Zhangjiang Science &Technology Investment Corporation (ZJSTIC), as well as private investors related to the...


Source:http://www.prnewswire.com/news-releases/anpac-bio-receives-series-b-funding-from-shanghai-zhangjiang-science--technology-investment-corp--private-insurance-investors-300197135.html

Related News
» Realiteer Rings in the Holidays with Christmas Edition of GermBuster Virtual Reality Game » Com realidade virtual, a G2A.com apresenta a primeira versão do "G2A Land" na Comic Con, em Mumbai